 Home > Active Ingredient News > Antitumor Therapy > Most people are in the middle and advanced stages of diagnosis at the time of diagnosis, what are the treatments for non-small cell lung cancer?

Most people are in the middle and advanced stages of diagnosis at the time of diagnosis, what are the treatments for non-small cell lung cancer?

 Last Update: 2022-10-01
 Source: Internet
 Author: User

▎Editor of WuXi AppTec content team

Editor's note: Worldwide, cancer places a heavy burden on public health and the economy, and according to the International Agency for Research on Cancer (IARC), in 2020 alone, nearly 10 million people died of cancer worldwide and more than 19 million
new cancer diagnoses were confirmed.

At the same time, cancer is also one of the most concerned areas in the pharmaceutical industry, with innovative therapies emerging over the past few years
.

In order to share the latest cancer therapies around the world in a timely manner, WuXi AppTec's content team will also do a series of inventory to introduce readers to the relevant information
of authoritative cancer societies overseas.

This article is for informational purposes only and the views expressed in this article do not represent the position of WuXi AppTec and do not represent that WuXi AppTec supports or disagrees with the views in this article
.

This article is also not a recommended
treatment plan.

For guidance on treatment options, visit a regular hospital
.

Lung cancer is the most common type of cancer and the leading cause
of cancer death.

Image source: 123RF

What are the targeted therapies for NSCLC?

Image source: 123RF

What immunotherapies are available for NSCLC?

Immunotherapy refers to the use of a person's immune system to fight diseases such as cancer
.

Image source: 123RF

epilogue

In recent years, the rapid development of targeted therapies and immune checkpoint inhibitors has greatly changed the treatment landscape of NSCLC, and the maturity of these therapies has brought new hope for a cure for the majority of patients
.

WuXi AppTec provides integrated, end-to-end new drug development and manufacturing services to the global biopharmaceutical industry, covering the fields
of chemical drug development and production, biological research, preclinical testing and clinical trial development, cell and gene therapy development, testing and production.

If you have relevant business needs, please click on the picture below to fill in the specific information
.

▲If you have any business needs, please long press to scan the QR code above, or

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.